<DOC>
	<DOCNO>NCT01634789</DOCNO>
	<brief_summary>The purpose study evaluate 3 test formulation relative reference formulation .</brief_summary>
	<brief_title>A Pilot Bioavailability Study 3 Test Tablet Formulations Bazedoxifene Compared With A Reference Tablet Formulation Bazedoxifene/Conjugated Estrogens Healthy Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Generally healthy postmenopausal woman Body mass index ( BMI ) range 18.0 35.0 kg/m2 body weight &gt; = 50 kg Pregnant nursing female ; female childbearing potential</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>bioavailability</keyword>
</DOC>